Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)

Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis

NCT02831855 ·Status: COMPLETED ·Phase: PHASE4

Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics

NCT03964649 ·Status: COMPLETED

Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis Patients

NCT04079920 ·Status: COMPLETED

Patient-Reported Outcomes In Rheumatoid Arthritis Patients Treated With Tofacitinib Or Biological Disease-Modifying Antirheumatic Drugs (DMARDs) In Real Life Conditions

NCT03073109 ·Status: COMPLETED

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

NCT02187055 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

NCT05572567 ·Status: COMPLETED

The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis

NCT05133297 ·Status: COMPLETED ·Phase: PHASE2

Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.

NCT04721821 ·Status: COMPLETED

A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)

NCT01893255 ·Status: WITHDRAWN

A Study of Tocilizumab in Patients With Rheumatoid Arthritis

NCT01187563 ·Status: COMPLETED

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

NCT02092467 ·Status: COMPLETED ·Phase: PHASE4

Rheumatoid Arthritis Satisfaction Outcome Research

NCT03703817 ·Status: COMPLETED

An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective

NCT02566967 ·Status: COMPLETED ·Phase: PHASE3

Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)-Cancer Endpoints

NCT04798287 ·Status: COMPLETED

A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs

NCT06020144 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.

NCT01010503 ·Status: COMPLETED ·Phase: PHASE4

An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)

NCT01565122 ·Status: COMPLETED

To Compare the Efficacy and Safety of Low-dose Glucocorticoids and Tofacitinib in Alleviating Moderate to High Disease Activity Rheumatoid Arthritis for 24 Weeks

NCT05606107 ·Status: UNKNOWN ·Phase: PHASE4

Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA)

NCT01164579 ·Status: COMPLETED ·Phase: PHASE2

A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

NCT00891020 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis

NCT01976364 ·Status: COMPLETED ·Phase: PHASE3

IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis

NCT03981900 ·Status: COMPLETED

A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

NCT00531817 ·Status: COMPLETED ·Phase: PHASE3

Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis

NCT04674085 ·Status: COMPLETED

Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis

NCT03011281 ·Status: UNKNOWN